Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Medulloblastoma
  • Age: Between 3 - 22 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:

    1. Patients must be newly diagnosed or be previously untreated for medulloblastoma (M0) or diffusely anaplastic medulloblastoma

    2. Patients must have a pre-operative magnetic resonance imaging (MRI) scan of the brain with and without contrast

    3. Spinal MRI imaging with and without gadolinium is required


You may not be eligible for this study if the following are true:

  • 1.  Previous chemotherapy or radiation therapy

    2.  Use of other experimental therapy




If you are registered as a volunteer, please login to the dashboard to send referrals.